Good At

Engaged in the diagnosis and standardized treatment of hematological malignancies, combined with the annual international guidelines and the accumulated experience of diagnosis and treatment in this department, it has carried out a large number of innovative practices in the stratification of leukemia risk and individualized treatment, significantly improving the patient's remission period and life quality. Be proficient in the standardization of lymphoma and myeloma.

Introduction

Doctor of Medicine, Chief Physician, Master Supervisor Special Committee on Integrated Rehabilitation of Lymphoma of China Anti-Cancer Association--Member European Society for Blood and Bone Marrow Transplantation (EBMT)-Member Youth Committee of the 11th Committee of the Hematology Specialized Branch of Shanghai City Medical Association--Vice Chairman The Second Youth Committee of the Hematology and Oncology Professional Committee of China Anti-Cancer Association-Member The 1st Professional Committee for the Safety Management of Anti-Tumor Drugs of Shanghai Anti-Cancer Association--Member Hematopoietic Stem Cell Transplantation Group of the 12th Committee of the Hematology Specialized Branch of Shanghai City Medical Association--Member The First Shanghai Hematopoietic Stem Cell Transplantation Alliance--Member The First Youth Study Group of the Hematology Specialized Branch of Shanghai City Medical Association-Member Professional Committee of Hematology, Society of Integrated Traditional Chinese and Western Medicine, Shanghai City Medical Association--Member Visiting scholar at Temple University's FoxChase Cancer Center and Stem Cell Transplantation Center, USA Hosted many topics such as the National Natural Science Foundation and the Municipal Science and Technology Commission